Immersive Virtual Reality Training for Phlebotomy Skills in Nursing Students
The Effect of Immersive VR Phlebotomy on Nursing Students Self-efficacy, Anxiety and Clinical Performance: Randomize Clinical Trial
This randomized controlled trial aims to evaluate the effect of immersive virtual reality (VR) training on nursing students' learning outcomes in phlebotomy skills. The study compares immersive VR-based simulation with traditional task trainer-based simulation.
A total sample of undergraduate nursing students is randomly assigned to either the experimental group (VR training) or the control group (task trainer training). The intervention focuses on improving self-efficacy, reducing anxiety, and enhancing clinical performance in venipuncture skills.
Outcomes are measured at three time points: pre-test, immediate post-test, and follow-up. Self-efficacy, anxiety, and clinical performance are assessed using validated scales.
The study seeks to determine whether immersive VR provides a more effective and engaging learning experience compared to conventional simulation methods in nursing education.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Jerusalem
-
Abū Dīs, Jerusalem, Territorios palestinos, 5100
- Al-Quds University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Second-year nursing students who enrolled in the Adult Health Nursing I course, had no prior clinical experience in venipuncture, and were willing to participate in the study. Additional inclusion criteria included the ability to attend training sessions using both immersive virtual reality (VR) and a part-task trainer simulation and commitment to completing all training and assessment sessions. Written informed consent was obtained from all participants before enrollment.
Exclusion Criteria:
if they had previous advanced or extensive practical experience in venipuncture or had participated in external training programs related to the same skill. Additional exclusion criteria included the presence of physical or psychological conditions that could interfere with participation or performance during training, failure to attend scheduled training sessions, incomplete participation in the study procedures, or withdrawal of consent.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Immersive Virtual Reality Training Group
|
Immersive VR-based phlebotomy training simulation designed to improve self-efficacy, reduce anxiety, and enhance clinical performance.
|
|
Comparador activo: Part-Task Trainer Simulation Group
|
Traditional phlebotomy training using a part-task trainer arm simulation.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Self-efficacy
Periodo de tiempo: Baseline, immediately post-intervention, and two-week follow-up
|
Measured using a validated self-efficacy scale for clinical skills.
|
Baseline, immediately post-intervention, and two-week follow-up
|
|
Clinical performance
Periodo de tiempo: Baseline, immediately post-intervention, and two-week follow-up
|
Assessed using a structured checklist evaluating steps of the phlebotomy procedure.
|
Baseline, immediately post-intervention, and two-week follow-up
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Anxiety related to phlebotomy skill
Periodo de tiempo: Baseline, immediately post-intervention, and at the 2-week follow-up.
|
State-Trait Anxiety Inventory (STAI-S) - State version (STAI-S)
|
Baseline, immediately post-intervention, and at the 2-week follow-up.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- RESC/2026-72
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .